» Articles » PMID: 24005859

Liberation of GPI-anchored Prion from Phospholipids Accelerates Amyloidogenic Conversion

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2013 Sep 6
PMID 24005859
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Prion diseases or transmissible spongiform encephalopathies are a rare group of fatal neurodegenerative illnesses in humans and animals caused by misfolding of prion protein (PrP). Prion protein is a cell-surface glycosylphosphatidylinositol (GPI)-anchored glycoprotein expressed mostly in the central and peripheral nervous system, and this membrane-bound protein can be cleaved from the cell membranes by phosphoinositide phospholipase C. Numerous studies have investigated GPI-free recombinant PrP, but the role of GPI on misfolding of PrP is not well known. In this study, we synthesized a GPI analog that was covalently linking to a PrP S230C mutant, resulting in S230C-GPI. The structural changes in S230C-GPI upon binding to lipid vesicles composed of mixtures of the zwitterionic lipid (POPC) and the anionic lipid (POPG) were analyzed by circular dichroism spectroscopy, and the amyloid aggregation of S230C-GPI in the liberation from phospholipid vesicles was monitored by proteinase K-digestion assay. Our results indicate that S230C-GPI in the liberation of lipid vesicles has high tendency to misfold into amyloid fibrils, while the membrane-bound S230C-GPI proteins are highly stable and rarely convert into amyloid forms. In addition, the role of cholesterol in S230C-GPI was studied. The effect of GPI, cholesterol and phospholipid vesicles on misfolding of PrP is further discussed.

Citing Articles

The Effect of Octapeptide Repeats on Prion Folding and Misfolding.

Yu K, Huang M, Lee Y, Lin Y, Chen H, Lee C Int J Mol Sci. 2021; 22(4).

PMID: 33670336 PMC: 7918816. DOI: 10.3390/ijms22041800.


Quercetin Disaggregates Prion Fibrils and Decreases Fibril-Induced Cytotoxicity and Oxidative Stress.

Yu K, Lee C Pharmaceutics. 2020; 12(11).

PMID: 33187342 PMC: 7696844. DOI: 10.3390/pharmaceutics12111081.


The Effects of Divalent Cation-Chelated Prion Fibrils on the Immune Response of EOC 13.31 Microglia Cells.

Jen H, Lin Z, Guo J, Lee C Cells. 2020; 9(10).

PMID: 33066249 PMC: 7602007. DOI: 10.3390/cells9102285.


Simulations of membrane-bound diglycosylated human prion protein reveal potential protective mechanisms against misfolding.

Cheng C, Koldso H, van der Kamp M, Schiott B, Daggett V J Neurochem. 2017; 142(1):171-182.

PMID: 28407243 PMC: 5500178. DOI: 10.1111/jnc.14044.

References
1.
Elfrink K, Ollesch J, Stohr J, Willbold D, Riesner D, Gerwert K . Structural changes of membrane-anchored native PrP(C). Proc Natl Acad Sci U S A. 2008; 105(31):10815-9. PMC: 2504809. DOI: 10.1073/pnas.0804721105. View

2.
Morillas M, Swietnicki W, Gambetti P, Surewicz W . Membrane environment alters the conformational structure of the recombinant human prion protein. J Biol Chem. 1999; 274(52):36859-65. DOI: 10.1074/jbc.274.52.36859. View

3.
Wang F, Yang F, Hu Y, Wang X, Wang X, Jin C . Lipid interaction converts prion protein to a PrPSc-like proteinase K-resistant conformation under physiological conditions. Biochemistry. 2007; 46(23):7045-53. DOI: 10.1021/bi700299h. View

4.
Friedrichson T, Kurzchalia T . Microdomains of GPI-anchored proteins in living cells revealed by crosslinking. Nature. 1998; 394(6695):802-5. DOI: 10.1038/29570. View

5.
Tsiroulnikov K, Shchutskaya Y, Muronetz V, Chobert J, Haertle T . Phospholipids influence the aggregation of recombinant ovine prions. From rapid extensive aggregation to amyloidogenic conversion. Biochim Biophys Acta. 2009; 1794(3):506-11. DOI: 10.1016/j.bbapap.2008.12.002. View